|
SNHG4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.372500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.060700E-03 |
| Normal-vs-Stage2 |
1.274810E-01 |
| Normal-vs-Stage3 |
9.295700E-02 |
| Normal-vs-Stage4 |
1.226440E-01 |
| Stage1-vs-Stage2 |
7.156600E-01 |
| Stage1-vs-Stage3 |
5.009400E-01 |
| Stage1-vs-Stage4 |
1.697380E-01 |
| Stage2-vs-Stage3 |
7.752000E-01 |
| Stage2-vs-Stage4 |
1.907620E-01 |
| Stage3-vs-Stage4 |
2.157000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.639300E-03 |
| Normal-vs-AfricanAmerican |
2.272000E-02 |
| Normal-vs-Asian |
6.707700E-02 |
| Caucasian-vs-AfricanAmerican |
8.427800E-01 |
| Caucasian-vs-Asian |
9.462600E-01 |
| AfricanAmerican-vs-Asian |
8.841200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.597200E-03 |
| Normal-vs-Female |
7.550400E-04 |
| Male-vs-Female |
3.111200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.755900E-02 |
| Normal-vs-Extreme_Weight |
3.402200E-02 |
| Normal-vs-Obese |
1.903600E-02 |
| Normal-vs-Extreme_Obese |
2.093800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.008000E-01 |
| Normal_Weight-vs-Obese |
5.134400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.963000E-01 |
| Extreme_Weight-vs-Obese |
4.110600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.822000E-01 |
| Obese-vs-Extreme_Obese |
4.565800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.839600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.435400E-03 |
| Normal-vs-Age(61-80Yrs) |
6.923200E-03 |
| Normal-vs-Age(81-100Yrs) |
9.471200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.946600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.700100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.850200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.171000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.088080E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.032100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.819900E-03 |
| Normal-VS-Type2 PRCC |
5.384200E-02 |
| Normal-VS-KIRP CIMP |
5.132400E-02 |
| Normal-VS-Unclassified PRCC |
3.242200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.543400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.047600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.342400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.167000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.796200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.765430E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.477500E-02 |
| Normal-vs-N1 |
6.159600E-02 |
| Normal-vs-N2 |
2.152000E-01 |
| N0-vs-N1 |
1.013830E-01 |
| N0-vs-N2 |
2.661800E-01 |
| N1-vs-N2 |
9.905400E-01 |
|
|
